Skip to main content
World Journal of Nuclear Medicine logoLink to World Journal of Nuclear Medicine
letter
. 2015 Jan-Apr;14(1):68. doi: 10.4103/1450-1147.150562

Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction

Sim Sai Tin 1,, Viroj Wiwanitkit 1
PMCID: PMC4337015  PMID: 25709552

Dear Editor,

The report on “Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction” is very interesting.[1] Senthilkumar and Sathasivasubramanian concluded that “there was a significant correlation between salivary flow rate and the scintigraphic uptake and excretory ratio.”[1] In fact, there is a previous similar report confirmed the good diagnostic protery of salivary gland scintigraphy.[2] Nevertheless, the false positive of the technique can be expected.[3] Salanci and Ergün noted that “bilateral radioactivity absence is observed usually due to drugs or radiopharmaceutical storage conditions.”[3] In case of existed salivary tumor, Yoshikai et al. noted that “adenoid cystic carcinomas and pleomorphic adenomas were the principal sources of false negative and false positive results, respectively.”[4]

References

  • 1.Senthilkumar B, Sathasivasubramanian S. The role of salivary gland scintigraphy in the evaluation of salivary gland dysfunction in uncontrolled type II diabetic patients. World J Nucl Med. 2013;12:94–100. doi: 10.4103/1450-1147.136733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Raza H, Khan AU, Hameed A, Khan A. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun. 2006;27:495–9. doi: 10.1097/00006231-200606000-00004. [DOI] [PubMed] [Google Scholar]
  • 3.Salanci BV, Ergün EL. Patterns of salivary gland uptake in I-131 MIBG scintigraphy. Rev Esp Med Nucl. 2006;25:198–201. doi: 10.1157/13088418. [DOI] [PubMed] [Google Scholar]
  • 4.Yoshikai T, Ishimaru J, Satoh T, Inokuchi A, Kudo S. The limitations of gallium scintigraphy in the differentiation between benign and malignant salivary gland mass lesions. Nucl Med Commun. 2003;24:657–62. doi: 10.1097/00006231-200306000-00007. [DOI] [PubMed] [Google Scholar]

Articles from World Journal of Nuclear Medicine are provided here courtesy of Thieme Medical Publishers

RESOURCES